SM
LLY icon

SG3 Management’s Eli Lilly LLY Stock Holding History

SG3 Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-28,500
Closed -$7.87M – 1198
2021
Q4 		$7.87M Hold
28,500
– – 0.16% 119
2021
Q3 		$6.58M Sell
28,500
-2,600
-8% -$642K 0.2% 103
2021
Q2 		$7.14M Buy
31,100
+12,600
+68% +$2.53M 0.25% 85
2021
Q1 		$3.46M Buy
+18,500
New +$3.62M 0.09% 266
2019
Q2 		– Sell
-175,000
Closed -$22.7M – 464
2019
Q1 		$22.7M Buy
+175,000
New +$21.3M 2.25% 8

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SG3 Management's LLY Position: Q2 2019 in Review

SG3 Management sold out of Eli Lilly (LLY) in Q2 2019, closing a stake of 17,000 shares — an estimated $2.21M sold.

SG3 Management first reported a position in LLY in Q1 2019 and held it in 1 quarter. The position peaked at $2.21M in Q1 2019. 1,516 funds tracked by Wall St. Rank hold LLY as of Q2 2019.

  • SG3 Management reported no remaining Eli Lilly position as of Q2 2019 after selling out during the quarter.
  • SG3 Management sold 17,000 Eli Lilly shares in Q2 2019, an estimated $2.21M.
  • SG3 Management first reported a position in Eli Lilly in Q1 2019 and held it in 1 quarter.
  • SG3 Management's Eli Lilly position peaked at $2.21M in Q1 2019.
  • 1,516 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2019.

Based on SG3 Management's 13F filing for Q2 2019, filed 9 Aug 2019.